Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_assertion type Assertion NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_head.
- NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_assertion wasGeneratedBy ECO_0000203 NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_provenance.
- NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_assertion wasDerivedFrom befree-2016 NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_provenance.
- NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_assertion SIO_000772 17959715 NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_provenance.
- NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_assertion evidence source_evidence_literature NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_provenance.
- NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_assertion description "[Carrier frequency of the MLH1 -93 variant was higher in patients who developed therapy related acute myeloid leukaemia (t-AML) (75.0%, n = 12) or breast cancer (53.3%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637052.RAqETdz_JD71P8-NtEtCqaa5cRE2n8ladSofOYHlJoDzg130_provenance.